D'Orazio & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
577
-93
-14% -$39.3K 0.03% 270
2026
Q1
$317K Buy
670
+81
+14% +$40.8K 0.04% 188
2025
Q4
$275K Buy
589
+66
+13% +$30.6K 0.04% 204
2025
Q3
$223K Sell
523
-1
-0.2% -$388 0.03% 235
2025
Q2
$201K Buy
+524
New +$189K 0.03% 258
2021
Q4
Sell
-161
Closed -$39K 348
2021
Q3
$39K Buy
+161
New +$39.4K 0.01% 241

Other funds holding HCA

D'Orazio & Associates's HCA Position: Q2 2026 in Review

D'Orazio & Associates reduced its HCA Healthcare (HCA) stake by 14% in Q2 2026, selling an estimated $39.3K and leaving 577 shares worth $225K. The position accounts for 0.03% of the portfolio, ranked #270.

D'Orazio & Associates first reported a position in HCA in Q3 2021 and has held it in 6 quarters since. The position peaked at $317K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • D'Orazio & Associates held 577 shares of HCA Healthcare worth $225K as of Q2 2026.
  • D'Orazio & Associates sold 93 HCA Healthcare shares in Q2 2026, an estimated $39.3K.
  • HCA Healthcare made up 0.03% of D'Orazio & Associates's portfolio in Q2 2026, its #270 holding.
  • D'Orazio & Associates first reported a position in HCA Healthcare in Q3 2021 and has held it in 6 quarters since.
  • D'Orazio & Associates's HCA Healthcare position peaked at $317K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on D'Orazio & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.